1. 163 Lox-1-specific affimers block oxldl accumulation in vitro. (5th June 2017) Authors: De Siqueira, Jonathan; Abdul Zani, Izma; Russell, David; Wheatcroft, Stephen; Tomlinson, Darren; Homer-Vanniasinkam, Shervanthi; Ponnambalam, Sreenivasan Journal: Heart Issue: Volume 103(2017)Supplement 5 Page Start: A116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation. Issue 3 (19th September 2018) Authors: Foth, Mona; Ismail, Nur Faezah Binti; Kung, Jeng Sum Charmaine; Tomlinson, Darren; Knowles, Margaret A; Eriksson, Pontus; Sjödahl, Gottfrid; Salmond, Jonathan M; Sansom, Owen J; Iwata, Tomoko Journal: Journal of pathology Issue: Volume 246:Issue 3(2018) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes. (26th February 2015) Authors: King, Rhodri; Tiede, Christian; Simmons, Katie; Fishwick, Colin; Tomlinson, Darren; Ajjan, Ramzi Journal: Lancet Issue: Volume 385(2015)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗